220 related articles for article (PubMed ID: 15749437)
1. Letter to the neurology editor.
Vajda FJ
J Clin Neurosci; 2005 Feb; 12(2):210. PubMed ID: 15749437
[No Abstract] [Full Text] [Related]
2. Amiodarone and mortality in CHF and post-MI.
Zamorski M
J Fam Pract; 1998 Mar; 46(3):196-7. PubMed ID: 9519009
[No Abstract] [Full Text] [Related]
3. [Prevention of sudden death with antiarrhythmic agents after myocardial infarction].
Raviele A; Gasparini G
G Ital Cardiol; 1992 Apr; 22(4):463-7. PubMed ID: 1385246
[No Abstract] [Full Text] [Related]
4. [Sudden coronary death: what can be done to reduce it].
da Luz PL; Murad Neto A; de Barros LF; Leite JJ; Chagas AC; Pileggi FJ
Arq Bras Cardiol; 1980 Dec; 35(6):509-18. PubMed ID: 7259581
[No Abstract] [Full Text] [Related]
5. [Betablockers, anti-arrhythmia and anti-ischemia agents and other drugs ... in the follow-up of myocardial infarction].
Coumel P
Arch Mal Coeur Vaiss; 1990 Sep; 83(10):1497-9. PubMed ID: 1978650
[No Abstract] [Full Text] [Related]
6. [Prevention of arrhythmia in myocardial infarct (secondary prevention)].
Gertsch M
Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1181-7. PubMed ID: 2877483
[No Abstract] [Full Text] [Related]
7. Phenytoin after recovery from myocardial infarction. Controlled trial in 568 patients.
Lancet; 1971 Nov; 2(7733):1055-7. PubMed ID: 4106911
[No Abstract] [Full Text] [Related]
8. Prophylactic use of antiarrhythmic drugs following myocardial infarction: observations over 12 months.
Lovell RR; Prineas RJ; Vajda F
Singapore Med J; 1973 Sep; 14(3):211-3. PubMed ID: 4777856
[No Abstract] [Full Text] [Related]
9. [Cardiac Arrhythmia Suppression Trial: a disappointment?].
Magalhães CO
Arq Bras Cardiol; 1990 Sep; 55(3):153-4. PubMed ID: 2095719
[No Abstract] [Full Text] [Related]
10. [Cardiac arrhythmia suppression trial (CAST)].
Furlanello F
G Ital Cardiol; 1990 Feb; 20(2):171-6. PubMed ID: 2109715
[No Abstract] [Full Text] [Related]
11. Sudden cardiac death: risk, evaluation, and primary prevention.
Tommaso CL; Kehoe RF
Geriatrics; 1983 Jul; 38(7):42-8, 53. PubMed ID: 6852538
[No Abstract] [Full Text] [Related]
12. Clinical efficacy of antiarrhythmic drugs in prevention of sudden coronary death.
Winkle RA
Ann N Y Acad Sci; 1982; 382():247-57. PubMed ID: 6979282
[No Abstract] [Full Text] [Related]
13. [Sudden death in coronary heart disease].
Hansteen V
Tidsskr Nor Laegeforen; 1976 Oct; 96(28):1465-8. PubMed ID: 10640
[No Abstract] [Full Text] [Related]
14. [Progress in the prevention of arrhythmia following myocardial infarction].
Torresani J; Chevalier D; Saadjian A; Trigano JA; Arnould JL
Therapeutique; 1973 Nov; 49(9):595-600. PubMed ID: 4792903
[No Abstract] [Full Text] [Related]
15. Antiarrhythmic therapy in post myocardial infarction patients.
Cowan C; Campbell RW
Eur Heart J; 1986 May; 7 Suppl A():145-7. PubMed ID: 3720769
[No Abstract] [Full Text] [Related]
16. Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction.
Lewis WR
Clin Cardiol; 1997 Nov; 20(11):910. PubMed ID: 9383581
[No Abstract] [Full Text] [Related]
17. [Ventricular arrhythmias and sudden death: diagnostic, prognostic and therapeutic aspects].
Van Durme JP
Verh K Acad Geneeskd Belg; 1981; 43(3):129-84. PubMed ID: 7336827
[No Abstract] [Full Text] [Related]
18. [Report from the arrhythmia symposium in Amsterdam].
Brorsson L; Cullhed I; Ehn L; RydénL
Lakartidningen; 1972 Sep; 69(38):4180-2. PubMed ID: 4564097
[No Abstract] [Full Text] [Related]
19. [Antiarrhythmic drugs].
Mitamura H
Kokyu To Junkan; 1993 Nov; 41(11):1043-8. PubMed ID: 8256044
[No Abstract] [Full Text] [Related]
20. Preventive use of N-3 fatty acids.
Harris WS; O'Keefe JH
Circulation; 2003 Nov; 108(19):e139; author reply e139. PubMed ID: 14610002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
